Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 7:41pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Dendreon Corp. (DNDN)
At 5:00AM SGT:
29.44 USD
0.00 (0.00%)
MORE ON DNDN
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Dendreon Corporation
(NGM:DNDN) Delayed quote data
Last Trade:
29.44 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
29.44
Open:
N/A
Bid:
27.88
x 100
Ask:
29.66
x 100
1y Target Est:
36.44
Day's Range:
N/A - N/A
52wk Range:
2.55 - 30.90
Volume:
0
Avg Vol
(3m)
:
2,244,100
Market Cap:
3.41B
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-1.92
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add DNDN to Portfolio
Download Data
HEADLINES
This Stock Has Tremendous Upside
at Motley Fool
(Wed 2:30am)
5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
at Motley Fool
(Tue 10:44pm)
An Earnings Surprise of an Unusual Kind
at Motley Fool
(Tue 12:52am)
4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC
(Mon, Feb 8)
Is Biotech Back?
CNBC
(Mon, Feb 8)
[video] Is Biotech Back?
at CNBC
(Mon, Feb 8)
There's No Such Thing as an ETF Bubble
at TheStreet.com
(Mon, Feb 8)
4-Star Stocks Poised to Pop: Myriad Genetics
at Motley Fool
(Thu, Feb 4)
Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor Conference
PR Newswire
(Wed, Feb 3)
Ground Floor -- Going Up!
at Motley Fool
(Wed, Feb 3)
Dendreon: To Short or Not to Short?
at Seeking Alpha
(Tue, Feb 2)
Barron's: new drugs could help industry sales, shares
at Reuters
(Mon, Feb 1)
More Headlines for DNDN...
ANALYST
EPS Est (next year)
(Dec-09)
:
-1.68
EPS Est (in 2 years)
(Dec-10)
:
-0.59
Avg Rec (current)*:
1.6
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices